Transaction in Own Shares

Summary by AI BETAClose X

RTW Biotech Opportunities Ltd announced a transaction in its own shares on August 22, 2025. The company bought back 150,000 ordinary shares at a price of $1.40 per share. Following this purchase, the company holds 16,193,791 ordinary shares in treasury, leaving 329,773,649 total voting rights out of a total issued share capital of 345,967,440. This buyback was authorized by shareholders at the June 2025 Annual General Meeting, allowing for repurchases up to 14.99% of ordinary shares until the next AGM in 2026 or earlier revocation. The company intends to hold repurchased shares in treasury and Deutsche Numis acted as broker for these transactions.

Disclaimer*

UK 100

Latest directors dealings